342 related articles for article (PubMed ID: 6373933)
41. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.
Stukart MJ; Rijnsent A; Roos E
Cancer Res; 1987 Jul; 47(14):3880-5. PubMed ID: 3109735
[TBL] [Abstract][Full Text] [Related]
42. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
43. Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator CGP 31362 or CGP 19835A in combination with interleukin 2 or gamma-interferon.
Dinney CP; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
Cancer Res; 1992 Mar; 52(5):1155-61. PubMed ID: 1531322
[TBL] [Abstract][Full Text] [Related]
44. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
[TBL] [Abstract][Full Text] [Related]
45. Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study.
Gautam S; Deodhar S
J Biol Response Mod; 1989 Oct; 8(5):560-9. PubMed ID: 2795096
[TBL] [Abstract][Full Text] [Related]
46. Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.
Okutomi T; Inagawa H; Nishizawa T; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1990 Dec; 9(6):564-9. PubMed ID: 2074443
[TBL] [Abstract][Full Text] [Related]
47. Macrophage activation by MDP bound to neoglycoproteins: metastasis eradication in mice.
Roche AC; Bailly P; Monsigny M
Invasion Metastasis; 1985; 5(4):218-32. PubMed ID: 4008192
[TBL] [Abstract][Full Text] [Related]
48. Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
Kleinerman ES; Fogler WE; Fidler IJ
J Leukoc Biol; 1985 May; 37(5):571-84. PubMed ID: 3920339
[TBL] [Abstract][Full Text] [Related]
49. Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.
Fidler IJ; Fogler WE; Brownbill AF; Schumann G
J Immunol; 1987 Jun; 138(12):4509-14. PubMed ID: 3584979
[TBL] [Abstract][Full Text] [Related]
50. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
Petit C; Monsigny M; Roche AC
J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
[TBL] [Abstract][Full Text] [Related]
51. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG
Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005
[TBL] [Abstract][Full Text] [Related]
52. Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
Biochem Biophys Res Commun; 2000 Feb; 268(3):772-7. PubMed ID: 10679281
[TBL] [Abstract][Full Text] [Related]
53. In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cells.
Utsugi T; Dinney CP; Killion JJ; Brown D; Fidler IJ
Lymphokine Cytokine Res; 1991 Dec; 10(6):487-93. PubMed ID: 1804312
[TBL] [Abstract][Full Text] [Related]
54. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
55. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
[TBL] [Abstract][Full Text] [Related]
56. Treatment of experimental lung metastasis with local thoracic irradiation followed by systemic macrophage activation with liposomes containing muramyl tripeptide.
Saiki I; Milas L; Hunter N; Fidler IJ
Cancer Res; 1986 Oct; 46(10):4966-70. PubMed ID: 3756858
[TBL] [Abstract][Full Text] [Related]
57. [Effect of GMDP encapsulated into liposomes on metastatic spread of Lewis lung carcinoma].
Umanskiĭ VIu; Stefanov AV; Bondar' OP; Braginskiĭ SA; Balitskiĭ KP
Eksp Onkol; 1988; 10(5):40-3. PubMed ID: 2850149
[TBL] [Abstract][Full Text] [Related]
58. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice.
Yoo YC; Saiki I; Sato K; Azuma I
Vaccine; 1994 Feb; 12(2):175-60. PubMed ID: 8147100
[TBL] [Abstract][Full Text] [Related]
59. Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE.
Talmadge JE; Schneider M; Collins M; Phillips H; Herberman RB; Wiltrout RH
J Immunol; 1985 Aug; 135(2):1477-83. PubMed ID: 4008928
[TBL] [Abstract][Full Text] [Related]
60. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
Kleinerman ES; Erickson KL; Schroit AJ; Fogler WE; Fidler IJ
Cancer Res; 1983 May; 43(5):2010-4. PubMed ID: 6831430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
